Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/13/2025 | $35.00 | Buy | The Benchmark Company |
| 9/24/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 5/30/2024 | $20.00 | Market Perform → Outperform | Noble Capital Markets |
| 4/5/2024 | $25.00 | Buy | Lake Street |
| 3/27/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 2/26/2024 | $14.00 | Market Perform → Outperform | Noble Capital Markets |
| 11/27/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/14/2023 | $13.00 | Market Perform → Outperform | Noble Capital Markets |
Highly concerning nominee backgrounds underscore questionable judgment by Edward Smolyansky and George Sent, Managing Director of Cascadia Capital Edward and Ludmila Smolyansky's personal liquidity needs may be behind their demands for a quick sale of Lifeway at any price MORTON GROVE, Ill., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products, today issued the following statement in response to Edward Smolyansky's (the "Dissident") intent to nominate George Sent, Managing Director of Cascadia Capital, and the Dissident (the "Dissident Nominees") for election to the Company's Bo
CHICAGO, Dec. 11, 2025 /PRNewswire/ -- Edward Smolyansky, largest shareholder and nominee for director of Lifeway Foods, Inc. (Nasdaq: LWAY), issues letter and critical updates ahead of pivotal vote. Voting FOR the Shareholder Nominees, George Sent and Edward Smolyansky, is the Only Way to Restore Accountability THE PATH FORWARD If elected, we will take action immediately to: Reconstitute a functional, independent Board;Empower the Strategic Review Committee to initiate a credible sale process;Enforce strict compensation discipline;Restore transparency and shareholder trust.Pl
Letter Urges Shareholders to Vote the GREEN Universal Proxy Card for Nominees. CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Edward Smolyansky today announced that he has filed a Definitive Proxy Statement (DEFN14A) with the U.S. Securities and Exchange Commission in connection with the upcoming 2025 Annual Meeting of Shareholders of Lifeway Foods, Inc. (NASDAQ:LWAY). The action continues the effort toward comprehensive board change to finally end the long-running governance failures, value destruction, and entrenched leadership practices that have plagued the Company at the expense of its shareholders. Dear Shareholders, I, together with my mother and co-founder Ludmila Smolyansky, maintain signi
The Benchmark Company initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $35.00
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
3 - Lifeway Foods, Inc. (0000814586) (Issuer)
DEFR14A - Lifeway Foods, Inc. (0000814586) (Filer)
EFFECT - Lifeway Foods, Inc. (0000814586) (Filer)
424B3 - Lifeway Foods, Inc. (0000814586) (Filer)
Calls on Industry Partners to Join in Building a New Model for Public Health, Farmers,and Consumers MORTON GROVE, Ill., June 17, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, today announced that CEO Julie Smolyansky is launching an open industry-wide conversation to explore the creation of a new voluntary dairy certification standard. The proposal is designed to balance public health, consumer demand, and farmer viability — and to create a new model of trust and transparency in the dairy marketplace. The announcement is one of many initiatives coming from Lifeway Foods as part of their 40th anniversary plans and
Achieves $57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company's flagship Lifeway Kefir Record-breaking quarter marks six years of uninterrupted quarterly net sales growth Significant gross margin expansion of 300 basis points and net income growth of 19% reflects the Company's disciplined operational execution MORTON GROVE, Ill., Nov. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for the third quarter ended September 30, 2025.
MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect
Kefir market leader posts $53.9 million in net sales, an 18% volume-led net sales increase on a comparable basis, marking nearly six years of uninterrupted net sales growth Company posts double-digit diluted EPS gains and strong gross margin expansion year-over-year Momentum accelerates into Q3 with highest weekly sales ever recorded in July and unaudited estimate of $26.4 million in net sales for the third quarter-to-date through August 11, up over 20% year-over-year MORTON GROVE, Ill., Aug. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for th
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)